See every side of every news story
Get Started
SubscribeLogin
Pope Francis
Basketball
Donald Trump
Baseball
Vladimir Putin
Israel-Hamas Conflict
Ukraine War
Elon Musk
Premier League
Hamas
Immigration
Social Media
Published • loading... • Updated

DELTA TEEN Highlights Potential of Delgocitinib in Adolescents With Chronic Hand Eczema

Summary by dermatologytimes.com
The phase 3 clinical trial investigating delgocitinib cream for adolescents with moderate to severe CHE met its primary and key secondary endpoints.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
dermatologytimes.comdermatologytimes.com

DELTA TEEN Highlights Potential of Delgocitinib in Adolescents With Chronic Hand Eczema

The phase 3 clinical trial investigating delgocitinib cream for adolescents with moderate to severe CHE met its primary and key secondary endpoints.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

dermatologytimes.com broke the news in on Friday, February 21, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
Search
BlindspotLocal